Literature DB >> 27633955

Factors associated with remission of post-traumatic brain injury fatigue in the years following traumatic brain injury (TBI): a TBI model systems module study.

Anthony H Lequerica1, Amanda L Botticello1, Jean Lengenfelder1, Nancy Chiaravalloti1, Tamara Bushnik2, Marcel P Dijkers3, Flora M Hammond4, Stephanie A Kolakowsky-Hayner5, Joseph Rosenthal6.   

Abstract

Post-traumatic brain injury fatigue (PTBIF) is a major problem in the years after traumatic brain injury (TBI), yet little is known about its persistence and resolution. The objective of the study was to identify factors related to PTBIF remission and resolution. TBI Model System registrants at five centres participated in interviews at either one and two years post-injury (Y1-2 Cohort), or two and five years post-injury (Y2-5 Cohort). Characteristics of participants with PTBIF remission were compared to those with PTBIF persistence. Variables studied included the presence of and changes in disability, sleep dysfunction, mood, and community participation. The Functional Independence Measure did not differ significantly between groups or over time. In the Y1-2 Cohort the Fatigue Resolved group scored significantly better on the Disability Rating Scale and Pittsburgh Sleep Quality Index. In the Y2-5 Cohort the Fatigue Resolved group scored significantly higher on a measure of community participation. It was concluded that fewer than half of the sample in each cohort experienced a remission of PTBIF between time points. Persistence of PTBIF 1-2 years post-injury is associated with disability, sleep disturbance, and depression while persistence of fatigue beyond 2 years post-injury appears to be related to participation level, underscoring the potential impact of effective surveillance, assessment, and treatment of this condition in optimising life after TBI. Differences in fatigue progression may point to the presence of different types of PTBIF.

Entities:  

Keywords:  Fatigue; brain injury

Mesh:

Year:  2016        PMID: 27633955     DOI: 10.1080/09602011.2016.1231120

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  6 in total

1.  Fatigue Symptoms During the First Year Following ARDS.

Authors:  Karin J Neufeld; Jeannie-Marie S Leoutsakos; Haijuan Yan; Shihong Lin; Jeffrey S Zabinski; Victor D Dinglas; Megan M Hosey; Ann M Parker; Ramona O Hopkins; Dale M Needham
Journal:  Chest       Date:  2020-04-15       Impact factor: 9.410

Review 2.  Physical Activity Intolerance and Cardiorespiratory Dysfunction in Patients with Moderate-to-Severe Traumatic Brain Injury.

Authors:  Renee N Hamel; James M Smoliga
Journal:  Sports Med       Date:  2019-08       Impact factor: 11.136

3.  Military Injuries-Understanding Posttraumatic Epilepsy, Health, and Quality-of-Life Effects of Caregiving: Protocol for a Longitudinal Mixed Methods Observational Study.

Authors:  Erin D Bouldin; Roxana Delgado; Kimberly Peacock; Willie Hale; Ali Roghani; Amira Y Trevino; Mikayla Viny; David W Wetter; Mary Jo Pugh
Journal:  JMIR Res Protoc       Date:  2022-01-05

4.  Community Integration After Traumatic Brain Injury and Related Factors: A Study in the Nepalese Context.

Authors:  Sumana Lama; Jintana Damkliang; Luppana Kitrungrote
Journal:  SAGE Open Nurs       Date:  2020-12-21

Review 5.  The Traumatic Brain Injury Model Systems National Database: A Review of Published Research.

Authors:  Samantha Tso; Ashirbani Saha; Michael D Cusimano
Journal:  Neurotrauma Rep       Date:  2021-03-12

6.  The Military Injuries: Understanding Post-Traumatic Epilepsy Study: Understanding Relationships among Lifetime Traumatic Brain Injury History, Epilepsy, and Quality of Life.

Authors:  Mary Jo Pugh; Eamonn Kennedy; James J Gugger; Jamie Mayo; David Tate; Alicia Swan; Jacob Kean; Hamada Altalib; Shaila Gowda; Alan Towne; Sidney Hinds; Anne Van Cott; Maria R Lopez; Carlos A Jaramillo; Blessen C Eapen; Randall R McCafferty; Martin Salinsky; Joyce Cramer; Katherine K McMillan; Andrea Kalvesmaki; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2021-10-15       Impact factor: 4.869

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.